Enanta Pharma (ENTA) Tops Q1 EPS by 17c

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($1.39), $0.17 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $23.6 million versus the consensus estimate of $21.85 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• Lennar Corp. (LEN) Misses Q3 EPS by 10c
• UBS Reiterates Sell Rating on Macy's (M) on Price Challenges Vs. Peers
• S&P Global agrees to acquire blockchain security firm OpenZeppelin